Concepedia

J. Vanderkolk

JV

6

Publications

254

Citations

6

H-Index

1993

Active since

Affiliations

National Jewish Health(Current)

University of Colorado Denver

J. Vanderkolk is an author at National Jewish Health specializing in clinical microbiology, tuberculosis, and medicine.

Top concepts

MedicineMicrobiologyTuberculosisClinical MicrobiologyAntibioticsAntimicrobial ResistanceHealthPharmacologyDrug ResistanceInfection Control

Publications per year

1993–1999

6

Publications

6

Mycobacterium avium strains resistant to clarithromycin and azithromycin

Leonid Heifets, N Mor, J. Vanderkolk · Antimicrobial Agents and Chemotherapy · 1993 · 104 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +14

Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages

N Mor, J. Vanderkolk, Leonid Heifets · Antimicrobial Agents and Chemotherapy · 1994 · 65 citations · Full text

Pulmonary Tuberculosis, Infected Macrophages, Antimicrobial Susceptibility +15

Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium

N Mor, J. Vanderkolk, N Mezo et al. · Antimicrobial Agents and Chemotherapy · 1994 · 33 citations

Extracellular Replication, Bacteriology, Immunology +18

Accumulation of Clarithromycin in Macrophages Infected With <i>Mycobacterium avium</i>

Natan Mor, J. Vanderkolk, Leonid Heifets · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1994 · 25 citations

Development of Rifapentine Susceptibility Tests for <i>Mycobacterium tuberculosis</i>

Leonid Heifets, J. Vanderkolk, Van Hung Pham · Antimicrobial Agents and Chemotherapy · 1999 · 15 citations · Full text

Rows per page

1–5 of 6